Myeloproliferative neoplasia (MPN) with Eosinophilia has been categorized as a separate disease entity with the rearrangement of the genes - PDGFRA, PDGRB & FGFR1 by the recent (2016) revision to the WHO classification of Myeloid neoplasms & Acute leukemia. Identification of these dysregulated fusion Tyrosine kinase (TK) genes is crucial for the therapeutic strategy and prognostication of these otherwise BCR-ABL1 negative Myeloproliferative neoplasias. This panel is precisely designed to identify these Myeloproliferative neoplasias of clinical significance.

  • Test Type:
  • Pre-test Information:
    Give clinical history on Chromosome & FISH Analysis Test request form (Form 17).
  • Report Delivery:
    Sample Daily by 4 pm; Report 7 days
  • Components: